Page 179 – Clinical Laboratory int.

Advances in point-of-care hematology analysis

, 7 July 2021/in Featured Articles /by panglobal

Point-of-care hematology analysis can help to generate the data needed to make decisions about patient care quickly, both of which can improve patient outcomes in emergency situations and also help hospitals to meet waiting time targets safely. CLI asked Cleve Wright, Director of Medical HORIBA UK Ltd, about recent developments in this field.

Agilent announces new SureSelect Human All Exon V8

, 7 July 2021/in Product News /by Agilent Technologies Europe

Agilent Technologies has released SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein-coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture exons that are omitted by other exomes on the market. The new design is available in three options […]

Actim Oy antigen test for diagnosis of acute COVID-19 infection receives CE marking

, 7 July 2021/in Product News /by 3wmedia

The Finnish diagnostics company Actim Oy has recently received a CE mark for the new Actim SARS-CoV-2 rapid test. The test is intended for healthcare professionals and it detects the nucleoprotein of SARS-CoV-2 virus in the nasopharyngeal swab sample. The test has been shown to perform reliably with different variants of the coronavirus, such as […]

groen Fig 1 QuantiVac Correlation WHO Standard kopiëren 1

Investigation of SARS-CoV-2-specific immune responses

, 7 July 2021/in Featured Articles, Microbiology /by panglobal

A thorough understanding of the immune response to SARS-CoV-2 is necessary for the evaluation of the efficacy of vaccines and vaccine candidates against this virus. This article discusses how some parts of the humoral and cellular immune responses can be analysed to improve our understanding of how the body reacts to this virus.

Bruker Corp launches two new timsTOF instruments

, 7 July 2021/in Product News /by panglobal

Bruker Corporation has launched two new timsTOF instruments – the timsTOF SCP for unbiased single cell 4D-proteomics and the next-gen timsTOF Pro 2 with unprecedented proteomic depth. The instruments enable new applications and methods in unbiased proteomics, epiproteomics/PTM characterization, and unbiased, deep multiomic biomarker discovery, such as in cancer liquid biopsy research.

hr PAN0069 CLI magazine nr. 3 2021 page by page Pagina 40

Enhanced performance

, 7 July 2021/in Advertenties /by panglobal

Speeding up flow cytometry in clinical development

, 7 July 2021/in Featured Articles /by panglobal

Flow cytometry is one of many analytical techniques used in clinical development to help discover new biomarkers and aid in development of new therapies. This article highlights how automated gating can expedite data processing and management, leading to improved productivity and insights in flow cytometry analysis for clinical research.

Developments in optical fibre imaging: nano-ultrasonography and more

, 7 July 2021/in Featured Articles /by panglobal

Optical fibres have revolutionized clinical practice in the form of the optical endoscope, and are now providing the framework for an entirely new endoscopic paradigm: all-optical ultrasound. Here we describe a phonon probe, which offers a route towards cellular resolution acoustic imaging – while also offering new capabilities such as label-free contrast and parallel spectroscopy […]